nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.242	0.664	CbGbCtD
Pimecrolimus—CYP3A4—Colchicine—primary biliary cirrhosis	0.122	0.336	CbGbCtD
Pimecrolimus—Skin papilloma—Ursodeoxycholic acid—primary biliary cirrhosis	0.0155	0.0442	CcSEcCtD
Pimecrolimus—Skin papilloma—Chenodeoxycholic acid—primary biliary cirrhosis	0.0155	0.0442	CcSEcCtD
Pimecrolimus—Otitis media—Chenodeoxycholic acid—primary biliary cirrhosis	0.00648	0.0185	CcSEcCtD
Pimecrolimus—Otitis media—Ursodeoxycholic acid—primary biliary cirrhosis	0.00648	0.0185	CcSEcCtD
Pimecrolimus—Acne—Chenodeoxycholic acid—primary biliary cirrhosis	0.006	0.0171	CcSEcCtD
Pimecrolimus—Acne—Ursodeoxycholic acid—primary biliary cirrhosis	0.006	0.0171	CcSEcCtD
Pimecrolimus—Viral infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00559	0.016	CcSEcCtD
Pimecrolimus—Bone disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00559	0.016	CcSEcCtD
Pimecrolimus—Skin discolouration—Chenodeoxycholic acid—primary biliary cirrhosis	0.00559	0.016	CcSEcCtD
Pimecrolimus—Bone disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00559	0.016	CcSEcCtD
Pimecrolimus—Skin discolouration—Ursodeoxycholic acid—primary biliary cirrhosis	0.00559	0.016	CcSEcCtD
Pimecrolimus—Viral infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00559	0.016	CcSEcCtD
Pimecrolimus—Dysmenorrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00555	0.0158	CcSEcCtD
Pimecrolimus—Dysmenorrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00555	0.0158	CcSEcCtD
Pimecrolimus—Herpes simplex—Ursodeoxycholic acid—primary biliary cirrhosis	0.00548	0.0156	CcSEcCtD
Pimecrolimus—Herpes simplex—Chenodeoxycholic acid—primary biliary cirrhosis	0.00548	0.0156	CcSEcCtD
Pimecrolimus—MTOR—mTORC1-mediated signalling—RPS6KB1—primary biliary cirrhosis	0.005	0.018	CbGpPWpGaD
Pimecrolimus—Influenza like illness—Ursodeoxycholic acid—primary biliary cirrhosis	0.0049	0.014	CcSEcCtD
Pimecrolimus—Influenza like illness—Chenodeoxycholic acid—primary biliary cirrhosis	0.0049	0.014	CcSEcCtD
Pimecrolimus—MTOR—CXCR3-mediated signaling events—CXCL9—primary biliary cirrhosis	0.00427	0.0153	CbGpPWpGaD
Pimecrolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—CD40LG—primary biliary cirrhosis	0.0042	0.0151	CbGpPWpGaD
Pimecrolimus—MTOR—SREBF and miR33 in cholesterol and lipid homeostasis—PPARGC1A—primary biliary cirrhosis	0.0041	0.0147	CbGpPWpGaD
Pimecrolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IL4—primary biliary cirrhosis	0.00409	0.0147	CbGpPWpGaD
Pimecrolimus—MTOR—TSLP Signaling Pathway—IL7R—primary biliary cirrhosis	0.00404	0.0145	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling—CTGF—primary biliary cirrhosis	0.00373	0.0134	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—CD3D—primary biliary cirrhosis	0.00361	0.013	CbGpPWpGaD
Pimecrolimus—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00354	0.0101	CcSEcCtD
Pimecrolimus—Face oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00354	0.0101	CcSEcCtD
Pimecrolimus—FKBP1A—TOR Signaling—RPS6KB1—primary biliary cirrhosis	0.00344	0.0124	CbGpPWpGaD
Pimecrolimus—CYP3A4—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00341	0.0123	CbGpPWpGaD
Pimecrolimus—MTOR—Cardiac Hypertrophic Response—MAP3K14—primary biliary cirrhosis	0.00337	0.0121	CbGpPWpGaD
Pimecrolimus—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.00335	0.00955	CcSEcCtD
Pimecrolimus—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.00335	0.00955	CcSEcCtD
Pimecrolimus—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00331	0.00945	CcSEcCtD
Pimecrolimus—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00331	0.00945	CcSEcCtD
Pimecrolimus—MTOR—Costimulation by the CD28 family—CD3D—primary biliary cirrhosis	0.00327	0.0118	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling—TAB1—primary biliary cirrhosis	0.00317	0.0114	CbGpPWpGaD
Pimecrolimus—Asthma—Ursodeoxycholic acid—primary biliary cirrhosis	0.00317	0.00904	CcSEcCtD
Pimecrolimus—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.00317	0.00904	CcSEcCtD
Pimecrolimus—Asthma—Chenodeoxycholic acid—primary biliary cirrhosis	0.00317	0.00904	CcSEcCtD
Pimecrolimus—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.00317	0.00904	CcSEcCtD
Pimecrolimus—MTOR—ErbB1 downstream signaling—RPS6KA4—primary biliary cirrhosis	0.00312	0.0112	CbGpPWpGaD
Pimecrolimus—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00305	0.00869	CcSEcCtD
Pimecrolimus—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00305	0.00869	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00294	0.0084	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00294	0.0084	CcSEcCtD
Pimecrolimus—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00289	0.00825	CcSEcCtD
Pimecrolimus—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00289	0.00825	CcSEcCtD
Pimecrolimus—MTOR—IL12-mediated signaling events—IL12A—primary biliary cirrhosis	0.00288	0.0103	CbGpPWpGaD
Pimecrolimus—MTOR—Costimulation by the CD28 family—MAP3K14—primary biliary cirrhosis	0.00285	0.0102	CbGpPWpGaD
Pimecrolimus—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00284	0.00811	CcSEcCtD
Pimecrolimus—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00284	0.00811	CcSEcCtD
Pimecrolimus—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00282	0.00806	CcSEcCtD
Pimecrolimus—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00282	0.00806	CcSEcCtD
Pimecrolimus—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00282	0.00806	CcSEcCtD
Pimecrolimus—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00282	0.00806	CcSEcCtD
Pimecrolimus—FKBP1A—Spinal Cord Injury—AQP4—primary biliary cirrhosis	0.00277	0.00996	CbGpPWpGaD
Pimecrolimus—MTOR—CXCR4-mediated signaling events—CD3D—primary biliary cirrhosis	0.00276	0.00992	CbGpPWpGaD
Pimecrolimus—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00274	0.00784	CcSEcCtD
Pimecrolimus—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00274	0.00784	CcSEcCtD
Pimecrolimus—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00266	0.0076	CcSEcCtD
Pimecrolimus—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00266	0.0076	CcSEcCtD
Pimecrolimus—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00265	0.00756	CcSEcCtD
Pimecrolimus—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00265	0.00756	CcSEcCtD
Pimecrolimus—Eye disorder—Colchicine—primary biliary cirrhosis	0.00264	0.00753	CcSEcCtD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.00261	0.00937	CbGpPWpGaD
Pimecrolimus—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.0026	0.00934	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta receptor signaling—RPS6KB1—primary biliary cirrhosis	0.00256	0.00922	CbGpPWpGaD
Pimecrolimus—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00254	0.00726	CcSEcCtD
Pimecrolimus—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00254	0.00725	CcSEcCtD
Pimecrolimus—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00254	0.00725	CcSEcCtD
Pimecrolimus—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00252	0.00718	CcSEcCtD
Pimecrolimus—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00252	0.00718	CcSEcCtD
Pimecrolimus—Malnutrition—Colchicine—primary biliary cirrhosis	0.00246	0.00701	CcSEcCtD
Pimecrolimus—MTOR—FSH signaling pathway—RPS6KB1—primary biliary cirrhosis	0.00244	0.00876	CbGpPWpGaD
Pimecrolimus—MTOR—mTOR signalling—RPS6KB1—primary biliary cirrhosis	0.00244	0.00876	CbGpPWpGaD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—MAP3K14—primary biliary cirrhosis	0.0024	0.00864	CbGpPWpGaD
Pimecrolimus—MTOR—TSLP Signaling Pathway—STAT4—primary biliary cirrhosis	0.0024	0.00863	CbGpPWpGaD
Pimecrolimus—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00237	0.00676	CcSEcCtD
Pimecrolimus—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00237	0.00676	CcSEcCtD
Pimecrolimus—MTOR—PKB-mediated events—RPS6KB1—primary biliary cirrhosis	0.00237	0.0085	CbGpPWpGaD
Pimecrolimus—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00229	0.00654	CcSEcCtD
Pimecrolimus—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00229	0.00654	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00228	0.00652	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00228	0.00652	CcSEcCtD
Pimecrolimus—MTOR—CD28 dependent PI3K/Akt signaling—CD80—primary biliary cirrhosis	0.00228	0.00819	CbGpPWpGaD
Pimecrolimus—Angioedema—Colchicine—primary biliary cirrhosis	0.00224	0.00641	CcSEcCtD
Pimecrolimus—MTOR—Insulin Signaling—RPS6KA4—primary biliary cirrhosis	0.00223	0.00801	CbGpPWpGaD
Pimecrolimus—MTOR—CXCR3-mediated signaling events—CXCL10—primary biliary cirrhosis	0.00222	0.00799	CbGpPWpGaD
Pimecrolimus—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00221	0.0063	CcSEcCtD
Pimecrolimus—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00221	0.0063	CcSEcCtD
Pimecrolimus—CYP3A4—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.00218	0.00784	CbGpPWpGaD
Pimecrolimus—MTOR—Interferon type I signaling pathways—STAT4—primary biliary cirrhosis	0.00215	0.00772	CbGpPWpGaD
Pimecrolimus—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00213	0.00609	CcSEcCtD
Pimecrolimus—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00213	0.00609	CcSEcCtD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—CDH5—primary biliary cirrhosis	0.00213	0.00766	CbGpPWpGaD
Pimecrolimus—Arthralgia—Colchicine—primary biliary cirrhosis	0.00209	0.00597	CcSEcCtD
Pimecrolimus—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00202	0.00576	CcSEcCtD
Pimecrolimus—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00202	0.00576	CcSEcCtD
Pimecrolimus—MTOR—Signaling by VEGF—CDH5—primary biliary cirrhosis	0.00201	0.00723	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—STAT4—primary biliary cirrhosis	0.00197	0.0071	CbGpPWpGaD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—MMP13—primary biliary cirrhosis	0.00197	0.00708	CbGpPWpGaD
Pimecrolimus—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00197	0.00561	CcSEcCtD
Pimecrolimus—Skin disorder—Colchicine—primary biliary cirrhosis	0.00195	0.00556	CcSEcCtD
Pimecrolimus—MTOR—TOR Signaling—RPS6KB1—primary biliary cirrhosis	0.00194	0.00696	CbGpPWpGaD
Pimecrolimus—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.00193	0.0055	CcSEcCtD
Pimecrolimus—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.00193	0.0055	CcSEcCtD
Pimecrolimus—MTOR—IL2 signaling events mediated by PI3K—RPS6KB1—primary biliary cirrhosis	0.00189	0.0068	CbGpPWpGaD
Pimecrolimus—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00188	0.00536	CcSEcCtD
Pimecrolimus—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00188	0.00536	CcSEcCtD
Pimecrolimus—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.00187	0.00671	CbGpPWpGaD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00187	0.00533	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00187	0.00533	CcSEcCtD
Pimecrolimus—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.00185	0.00666	CbGpPWpGaD
Pimecrolimus—MTOR—Cardiac Hypertrophic Response—TNFRSF1A—primary biliary cirrhosis	0.00185	0.00665	CbGpPWpGaD
Pimecrolimus—MTOR—IL4-mediated signaling events—COL1A1—primary biliary cirrhosis	0.00185	0.00665	CbGpPWpGaD
Pimecrolimus—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.00183	0.00521	CcSEcCtD
Pimecrolimus—MTOR—IL12-mediated signaling events—IL12B—primary biliary cirrhosis	0.00181	0.0065	CbGpPWpGaD
Pimecrolimus—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.0018	0.00514	CcSEcCtD
Pimecrolimus—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.0018	0.00514	CcSEcCtD
Pimecrolimus—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00179	0.00511	CcSEcCtD
Pimecrolimus—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00179	0.00511	CcSEcCtD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—DAG1—primary biliary cirrhosis	0.00177	0.00636	CbGpPWpGaD
Pimecrolimus—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00177	0.00504	CcSEcCtD
Pimecrolimus—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00177	0.00504	CcSEcCtD
Pimecrolimus—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00175	0.00499	CcSEcCtD
Pimecrolimus—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00175	0.00499	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00173	0.00494	CcSEcCtD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—ELMO1—primary biliary cirrhosis	0.00172	0.0062	CbGpPWpGaD
Pimecrolimus—MTOR—RANKL/RANK Signaling Pathway—TAB1—primary biliary cirrhosis	0.00171	0.00613	CbGpPWpGaD
Pimecrolimus—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00468	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00468	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.00164	0.00468	CcSEcCtD
Pimecrolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00163	0.00586	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by VEGF—ELMO1—primary biliary cirrhosis	0.00163	0.00585	CbGpPWpGaD
Pimecrolimus—MTOR—CD28 co-stimulation—CD80—primary biliary cirrhosis	0.00163	0.00584	CbGpPWpGaD
Pimecrolimus—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00462	CcSEcCtD
Pimecrolimus—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00162	0.00462	CcSEcCtD
Pimecrolimus—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00458	CcSEcCtD
Pimecrolimus—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00458	CcSEcCtD
Pimecrolimus—FKBP1A—Spinal Cord Injury—CXCL10—primary biliary cirrhosis	0.0016	0.00574	CbGpPWpGaD
Pimecrolimus—Urticaria—Colchicine—primary biliary cirrhosis	0.00159	0.00455	CcSEcCtD
Pimecrolimus—Abdominal pain—Colchicine—primary biliary cirrhosis	0.00158	0.00452	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00155	0.00444	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00155	0.00444	CcSEcCtD
Pimecrolimus—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00154	0.0044	CcSEcCtD
Pimecrolimus—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00154	0.0044	CcSEcCtD
Pimecrolimus—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00154	0.0044	CcSEcCtD
Pimecrolimus—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00154	0.0044	CcSEcCtD
Pimecrolimus—MTOR—Costimulation by the CD28 family—CTLA4—primary biliary cirrhosis	0.00154	0.00553	CbGpPWpGaD
Pimecrolimus—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.00153	0.0055	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.00148	0.00422	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00147	0.0042	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00147	0.0042	CcSEcCtD
Pimecrolimus—MTOR—Insulin Signaling—MAP3K14—primary biliary cirrhosis	0.00144	0.00516	CbGpPWpGaD
Pimecrolimus—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00408	CcSEcCtD
Pimecrolimus—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00408	CcSEcCtD
Pimecrolimus—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00406	CcSEcCtD
Pimecrolimus—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00406	CcSEcCtD
Pimecrolimus—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00406	CcSEcCtD
Pimecrolimus—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00406	CcSEcCtD
Pimecrolimus—MTOR—epithelium—primary biliary cirrhosis	0.00141	0.201	CbGeAlD
Pimecrolimus—MTOR—ErbB Signaling Pathway—RPS6KB1—primary biliary cirrhosis	0.0014	0.00503	CbGpPWpGaD
Pimecrolimus—MTOR—Interferon type I signaling pathways—RPS6KB1—primary biliary cirrhosis	0.0014	0.00503	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Colchicine—primary biliary cirrhosis	0.00137	0.00391	CcSEcCtD
Pimecrolimus—MTOR—smooth muscle tissue—primary biliary cirrhosis	0.00136	0.194	CbGeAlD
Pimecrolimus—FKBP1A—Spinal Cord Injury—IL4—primary biliary cirrhosis	0.00133	0.00478	CbGpPWpGaD
Pimecrolimus—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00133	0.00379	CcSEcCtD
Pimecrolimus—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00133	0.00379	CcSEcCtD
Pimecrolimus—MTOR—mTOR signaling pathway—PPARGC1A—primary biliary cirrhosis	0.00132	0.00475	CbGpPWpGaD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—MMP3—primary biliary cirrhosis	0.00132	0.00474	CbGpPWpGaD
Pimecrolimus—MTOR—IL4-mediated signaling events—CD40LG—primary biliary cirrhosis	0.00129	0.00463	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—IL4—primary biliary cirrhosis	0.00129	0.00462	CbGpPWpGaD
Pimecrolimus—Vomiting—Colchicine—primary biliary cirrhosis	0.00127	0.00364	CcSEcCtD
Pimecrolimus—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00127	0.00364	CcSEcCtD
Pimecrolimus—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00127	0.00364	CcSEcCtD
Pimecrolimus—FKBP1A—epithelium—primary biliary cirrhosis	0.00127	0.181	CbGeAlD
Pimecrolimus—Rash—Colchicine—primary biliary cirrhosis	0.00126	0.00361	CcSEcCtD
Pimecrolimus—Dermatitis—Colchicine—primary biliary cirrhosis	0.00126	0.0036	CcSEcCtD
Pimecrolimus—Headache—Colchicine—primary biliary cirrhosis	0.00126	0.00358	CcSEcCtD
Pimecrolimus—MTOR—IL4-mediated signaling events—IL4—primary biliary cirrhosis	0.00125	0.0045	CbGpPWpGaD
Pimecrolimus—MTOR—IL4-mediated signaling events—RPS6KB1—primary biliary cirrhosis	0.00125	0.0045	CbGpPWpGaD
Pimecrolimus—FKBP1A—TGF-beta Receptor Signaling—NFKB1—primary biliary cirrhosis	0.00125	0.0045	CbGpPWpGaD
Pimecrolimus—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00352	CcSEcCtD
Pimecrolimus—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00123	0.00352	CcSEcCtD
Pimecrolimus—FKBP1A—smooth muscle tissue—primary biliary cirrhosis	0.00123	0.174	CbGeAlD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TAB1—primary biliary cirrhosis	0.00122	0.00437	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	0.00121	0.00437	CbGpPWpGaD
Pimecrolimus—MTOR—Senescence and Autophagy in Cancer—COL1A1—primary biliary cirrhosis	0.00121	0.00436	CbGpPWpGaD
Pimecrolimus—MTOR—TSH signaling pathway—RPS6KB1—primary biliary cirrhosis	0.00119	0.00428	CbGpPWpGaD
Pimecrolimus—MTOR—mTOR signaling pathway—RPS6KB1—primary biliary cirrhosis	0.00119	0.00428	CbGpPWpGaD
Pimecrolimus—Nausea—Colchicine—primary biliary cirrhosis	0.00119	0.0034	CcSEcCtD
Pimecrolimus—MTOR—PI3K Cascade—RPS6KB1—primary biliary cirrhosis	0.00116	0.00418	CbGpPWpGaD
Pimecrolimus—MTOR—Regulation of Telomerase—RPS6KB1—primary biliary cirrhosis	0.00116	0.00418	CbGpPWpGaD
Pimecrolimus—MTOR—AMPK Signaling—RPS6KB1—primary biliary cirrhosis	0.00115	0.00413	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—ALPL—primary biliary cirrhosis	0.00115	0.00412	CbGpPWpGaD
Pimecrolimus—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00327	CcSEcCtD
Pimecrolimus—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00327	CcSEcCtD
Pimecrolimus—MTOR—CDC42 signaling events—RPS6KB1—primary biliary cirrhosis	0.00114	0.00409	CbGpPWpGaD
Pimecrolimus—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00324	CcSEcCtD
Pimecrolimus—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00114	0.00324	CcSEcCtD
Pimecrolimus—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00324	CcSEcCtD
Pimecrolimus—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00324	CcSEcCtD
Pimecrolimus—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00322	CcSEcCtD
Pimecrolimus—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00322	CcSEcCtD
Pimecrolimus—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.00113	0.00405	CbGpPWpGaD
Pimecrolimus—MTOR—Leptin signaling pathway—RPS6KB1—primary biliary cirrhosis	0.00108	0.00387	CbGpPWpGaD
Pimecrolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.00107	0.00385	CbGpPWpGaD
Pimecrolimus—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00305	CcSEcCtD
Pimecrolimus—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00305	CcSEcCtD
Pimecrolimus—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.00107	0.00383	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—NOS2—primary biliary cirrhosis	0.00105	0.00377	CbGpPWpGaD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—HIF1A—primary biliary cirrhosis	0.00105	0.00376	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—NOS2—primary biliary cirrhosis	0.00101	0.00364	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-mediated signalling—RPS6KB1—primary biliary cirrhosis	0.000973	0.0035	CbGpPWpGaD
Pimecrolimus—MTOR—IL2 signaling events mediated by PI3K—NFKB1—primary biliary cirrhosis	0.000952	0.00342	CbGpPWpGaD
Pimecrolimus—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.000948	0.00341	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-related events—RPS6KB1—primary biliary cirrhosis	0.000947	0.0034	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-related events triggered by IGF1R—RPS6KB1—primary biliary cirrhosis	0.000938	0.00337	CbGpPWpGaD
Pimecrolimus—MTOR—Insulin receptor signalling cascade—RPS6KB1—primary biliary cirrhosis	0.000913	0.00328	CbGpPWpGaD
Pimecrolimus—MTOR—IGF1R signaling cascade—RPS6KB1—primary biliary cirrhosis	0.000913	0.00328	CbGpPWpGaD
Pimecrolimus—MTOR—Interferon type I signaling pathways—TYK2—primary biliary cirrhosis	0.000903	0.00325	CbGpPWpGaD
Pimecrolimus—MTOR—Costimulation by the CD28 family—CD80—primary biliary cirrhosis	0.00089	0.0032	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—ICAM3—primary biliary cirrhosis	0.000861	0.00309	CbGpPWpGaD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—AGT—primary biliary cirrhosis	0.000848	0.00305	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—TYK2—primary biliary cirrhosis	0.00083	0.00298	CbGpPWpGaD
Pimecrolimus—MTOR—liver—primary biliary cirrhosis	0.000802	0.114	CbGeAlD
Pimecrolimus—MTOR—TSLP Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000786	0.00283	CbGpPWpGaD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—TYK2—primary biliary cirrhosis	0.000779	0.0028	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—TAB1—primary biliary cirrhosis	0.000761	0.00273	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by Insulin receptor—RPS6KB1—primary biliary cirrhosis	0.000759	0.00273	CbGpPWpGaD
Pimecrolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—CD80—primary biliary cirrhosis	0.000737	0.00265	CbGpPWpGaD
Pimecrolimus—FKBP1A—liver—primary biliary cirrhosis	0.000721	0.103	CbGeAlD
Pimecrolimus—MTOR—RANKL/RANK Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000693	0.00249	CbGpPWpGaD
Pimecrolimus—MTOR—Cardiac Hypertrophic Response—NFKB1—primary biliary cirrhosis	0.000693	0.00249	CbGpPWpGaD
Pimecrolimus—FKBP1A—Spinal Cord Injury—MMP9—primary biliary cirrhosis	0.000677	0.00243	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—TAB1—primary biliary cirrhosis	0.00067	0.00241	CbGpPWpGaD
Pimecrolimus—MTOR—PI-3K cascade—CD80—primary biliary cirrhosis	0.000664	0.00239	CbGpPWpGaD
Pimecrolimus—MTOR—PI3K/AKT activation—CD80—primary biliary cirrhosis	0.000648	0.00233	CbGpPWpGaD
Pimecrolimus—MTOR—IL12-mediated signaling events—NFKB1—primary biliary cirrhosis	0.000647	0.00232	CbGpPWpGaD
Pimecrolimus—MTOR—GAB1 signalosome—CD80—primary biliary cirrhosis	0.000643	0.00231	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—RPS6KB1—primary biliary cirrhosis	0.000638	0.00229	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—CD79A—primary biliary cirrhosis	0.000632	0.00227	CbGpPWpGaD
Pimecrolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—CD80—primary biliary cirrhosis	0.000628	0.00226	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-mediated signalling—TYK2—primary biliary cirrhosis	0.000628	0.00226	CbGpPWpGaD
Pimecrolimus—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000625	0.00225	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-related events—TYK2—primary biliary cirrhosis	0.000611	0.0022	CbGpPWpGaD
Pimecrolimus—MTOR—Oncostatin M Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000607	0.00218	CbGpPWpGaD
Pimecrolimus—MTOR—IRS-related events triggered by IGF1R—TYK2—primary biliary cirrhosis	0.000606	0.00218	CbGpPWpGaD
Pimecrolimus—MTOR—Insulin receptor signalling cascade—TYK2—primary biliary cirrhosis	0.00059	0.00212	CbGpPWpGaD
Pimecrolimus—MTOR—IGF1R signaling cascade—TYK2—primary biliary cirrhosis	0.00059	0.00212	CbGpPWpGaD
Pimecrolimus—MTOR—Insulin Signaling—RPS6KB1—primary biliary cirrhosis	0.000587	0.00211	CbGpPWpGaD
Pimecrolimus—MTOR—Regulation of Telomerase—NFKB1—primary biliary cirrhosis	0.000585	0.0021	CbGpPWpGaD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—RPS6KB1—primary biliary cirrhosis	0.000581	0.00209	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD3D—primary biliary cirrhosis	0.000567	0.00204	CbGpPWpGaD
Pimecrolimus—MTOR—Leptin signaling pathway—NFKB1—primary biliary cirrhosis	0.000541	0.00194	CbGpPWpGaD
Pimecrolimus—MTOR—VEGFA-VEGFR2 Pathway—TYK2—primary biliary cirrhosis	0.000523	0.00188	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—ICAM3—primary biliary cirrhosis	0.000522	0.00188	CbGpPWpGaD
Pimecrolimus—MTOR—CXCR4-mediated signaling events—MMP9—primary biliary cirrhosis	0.000499	0.0018	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—CD80—primary biliary cirrhosis	0.000496	0.00178	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—MAP3K14—primary biliary cirrhosis	0.000494	0.00178	CbGpPWpGaD
Pimecrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—primary biliary cirrhosis	0.000494	0.00178	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by VEGF—TYK2—primary biliary cirrhosis	0.000493	0.00177	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by Insulin receptor—TYK2—primary biliary cirrhosis	0.00049	0.00176	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—CD80—primary biliary cirrhosis	0.000475	0.00171	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—CD80—primary biliary cirrhosis	0.000467	0.00168	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—SP100—primary biliary cirrhosis	0.000465	0.00167	CbGpPWpGaD
Pimecrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	0.000455	0.00164	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—ELMO1—primary biliary cirrhosis	0.000448	0.00161	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—CD80—primary biliary cirrhosis	0.000446	0.0016	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—CD80—primary biliary cirrhosis	0.000444	0.0016	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—CD80—primary biliary cirrhosis	0.000442	0.00159	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—CD80—primary biliary cirrhosis	0.00044	0.00158	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—CD80—primary biliary cirrhosis	0.000434	0.00156	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—ELMO1—primary biliary cirrhosis	0.000428	0.00154	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—TYK2—primary biliary cirrhosis	0.000419	0.00151	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—CD80—primary biliary cirrhosis	0.000414	0.00149	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—CD80—primary biliary cirrhosis	0.000414	0.00149	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—CD80—primary biliary cirrhosis	0.000414	0.00149	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—CD80—primary biliary cirrhosis	0.00041	0.00147	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—CD80—primary biliary cirrhosis	0.000407	0.00146	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—CD80—primary biliary cirrhosis	0.000405	0.00145	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—TYK2—primary biliary cirrhosis	0.000401	0.00144	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—TYK2—primary biliary cirrhosis	0.000395	0.00142	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—CD80—primary biliary cirrhosis	0.000383	0.00138	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—TYK2—primary biliary cirrhosis	0.000377	0.00135	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—TYK2—primary biliary cirrhosis	0.000375	0.00135	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—TYK2—primary biliary cirrhosis	0.000373	0.00134	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—TYK2—primary biliary cirrhosis	0.000371	0.00133	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000371	0.00133	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NUP210—primary biliary cirrhosis	0.000367	0.00132	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—CD80—primary biliary cirrhosis	0.000367	0.00132	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000357	0.00128	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—TYK2—primary biliary cirrhosis	0.000349	0.00126	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—TYK2—primary biliary cirrhosis	0.000349	0.00126	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—TYK2—primary biliary cirrhosis	0.000349	0.00126	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—TYK2—primary biliary cirrhosis	0.000346	0.00124	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD3D—primary biliary cirrhosis	0.000344	0.00124	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—TYK2—primary biliary cirrhosis	0.000343	0.00123	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—TYK2—primary biliary cirrhosis	0.000342	0.00123	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—HIF1A—primary biliary cirrhosis	0.000341	0.00122	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—MMP9—primary biliary cirrhosis	0.00033	0.00119	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000324	0.00116	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—NFKB1—primary biliary cirrhosis	0.000321	0.00115	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL7R—primary biliary cirrhosis	0.000316	0.00114	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—TYK2—primary biliary cirrhosis	0.000309	0.00111	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—NFKB1—primary biliary cirrhosis	0.000309	0.00111	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.0003	0.00108	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—MAP3K14—primary biliary cirrhosis	0.0003	0.00108	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—GOT2—primary biliary cirrhosis	0.00029	0.00104	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—primary biliary cirrhosis	0.000285	0.00103	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—CD80—primary biliary cirrhosis	0.000282	0.00101	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NFKB1—primary biliary cirrhosis	0.000272	0.000978	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CTLA4—primary biliary cirrhosis	0.000267	0.000959	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—ELMO1—primary biliary cirrhosis	0.000261	0.000938	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—TAB1—primary biliary cirrhosis	0.00026	0.000936	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD79A—primary biliary cirrhosis	0.000255	0.000915	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—NFKB1—primary biliary cirrhosis	0.000252	0.000906	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—GOT1—primary biliary cirrhosis	0.00025	0.0009	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—ELMO1—primary biliary cirrhosis	0.000241	0.000866	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—TYK2—primary biliary cirrhosis	0.000238	0.000855	CbGpPWpGaD
Pimecrolimus—CYP3A4—liver—primary biliary cirrhosis	0.000236	0.0335	CbGeAlD
Pimecrolimus—MTOR—Immune System—NUP210—primary biliary cirrhosis	0.000224	0.000803	CbGpPWpGaD
Pimecrolimus—Tacrolimus—ALB—primary biliary cirrhosis	0.000217	1	CrCbGaD
Pimecrolimus—MTOR—Signaling Pathways—CDH5—primary biliary cirrhosis	0.000208	0.000749	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD40LG—primary biliary cirrhosis	0.000208	0.000746	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NUP210—primary biliary cirrhosis	0.000206	0.000742	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.000201	0.000721	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—NFKB1—primary biliary cirrhosis	0.000198	0.000711	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—NFKB1—primary biliary cirrhosis	0.000185	0.000667	CbGpPWpGaD
Pimecrolimus—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	0.000183	0.000657	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000182	0.000655	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—HIF1A—primary biliary cirrhosis	0.000174	0.000626	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CXCL10—primary biliary cirrhosis	0.000169	0.000607	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000169	0.000606	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—GOT2—primary biliary cirrhosis	0.000163	0.000586	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CTLA4—primary biliary cirrhosis	0.000162	0.000582	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CD80—primary biliary cirrhosis	0.000161	0.000578	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NOS2—primary biliary cirrhosis	0.000158	0.00057	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD79A—primary biliary cirrhosis	0.000154	0.000555	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CD80—primary biliary cirrhosis	0.000154	0.000555	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MMP3—primary biliary cirrhosis	0.000154	0.000553	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CD80—primary biliary cirrhosis	0.000154	0.000553	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—TAB1—primary biliary cirrhosis	0.000152	0.000545	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CCL5—primary biliary cirrhosis	0.000145	0.000522	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—GOT1—primary biliary cirrhosis	0.000141	0.000506	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	0.000141	0.000506	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—TYK2—primary biliary cirrhosis	0.000136	0.000488	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—TYK2—primary biliary cirrhosis	0.00013	0.000467	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	0.000126	0.000453	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD40LG—primary biliary cirrhosis	0.000126	0.000453	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HIF1A—primary biliary cirrhosis	0.000122	0.000438	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—AGT—primary biliary cirrhosis	0.000122	0.000437	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CD80—primary biliary cirrhosis	0.000108	0.000387	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—NFKB1—primary biliary cirrhosis	0.000106	0.00038	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—NFKB1—primary biliary cirrhosis	0.000102	0.000365	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—HIF1A—primary biliary cirrhosis	9.8e-05	0.000352	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CXCL10—primary biliary cirrhosis	9.49e-05	0.000341	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CD80—primary biliary cirrhosis	9.37e-05	0.000337	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	9.1e-05	0.000327	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TYK2—primary biliary cirrhosis	9.09e-05	0.000327	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOS2—primary biliary cirrhosis	8.91e-05	0.00032	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MMP3—primary biliary cirrhosis	8.66e-05	0.000311	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CD80—primary biliary cirrhosis	8.65e-05	0.000311	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL5—primary biliary cirrhosis	8.17e-05	0.000294	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	8.11e-05	0.000292	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	7.92e-05	0.000285	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—TYK2—primary biliary cirrhosis	7.91e-05	0.000284	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	7.63e-05	0.000274	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	7.63e-05	0.000274	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—TYK2—primary biliary cirrhosis	7.3e-05	0.000262	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MMP9—primary biliary cirrhosis	7.16e-05	0.000257	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NFKB1—primary biliary cirrhosis	7.08e-05	0.000255	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HIF1A—primary biliary cirrhosis	6.86e-05	0.000247	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—AGT—primary biliary cirrhosis	6.84e-05	0.000246	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—NFKB1—primary biliary cirrhosis	6.16e-05	0.000221	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CD80—primary biliary cirrhosis	6.06e-05	0.000218	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TYK2—primary biliary cirrhosis	5.11e-05	0.000184	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	4.58e-05	0.000165	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	4.26e-05	0.000153	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MMP9—primary biliary cirrhosis	4.03e-05	0.000145	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.98e-05	0.000143	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	3.66e-05	0.000131	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	3.62e-05	0.00013	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	3.13e-05	0.000112	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	3.13e-05	0.000112	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	2.78e-05	0.0001	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	2.17e-05	7.79e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	1.66e-05	5.98e-05	CbGpPWpGaD
